GlassScriptPhysician profile
Joseph W Lanese
NPI 1144339862
$16,487.27
in general payments reported to CMS, 2019-2025
51 companies · $1,990 in 2025
The $1,990 reported for 2025 was more than what 93% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,541 · 2020: $2,685 · 2021: $3,437 · 2022: $2,273 · 2023: $1,608 · 2024: $1,954 · 2025: $1,990.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,494 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $37.00 · Education: $20.97.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,493.62 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $37.00 |
| Education | $20.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $2,494.53 | 2019-2025 | Farxiga, Breztri, Airsupra |
| Novo Nordisk INC | $2,177.43 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Amgen INC. | $1,604.82 | 2019-2025 | Otezla, Repatha, Otezla |
| Glaxosmithkline, LLC. | $1,564.56 | 2019-2025 | Trelegy Ellipta, Arexvy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,156.76 | 2019-2025 | Jardiance, Ofev, Synjardy |
| Abbvie INC. | $1,048.75 | 2021-2025 | |
| Janssen Pharmaceuticals, INC | $534.64 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $513.54 | 2019-2024 | |
| Sanofi-Aventis U.S. LLC | $489.97 | 2019-2025 | |
| Lilly USA, LLC | $456.83 | 2019-2025 | Mounjaro, Zepbound, Kisunla |
| Pfizer INC. | $450.03 | 2019-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $387.54 | 2021-2025 | |
| Allergan, INC. | $386.46 | 2019-2020 | |
| Amarin Pharma, INC. | $311.08 | 2019-2021 | |
| Eisai INC. | $285.21 | 2020-2021 |
Show all 51 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Esperion Therapeutics, INC. | $263.18 | 2020-2021 | |
| Merck Sharp & Dohme LLC | $180.24 | 2019-2021 | |
| Abbott Laboratories | $171.33 | 2023-2025 | Freestyle Libre 2, Freestyle Libre 3 |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $155.33 | 2019-2020 | |
| Comsort, INC | $150.00 | 2019 | |
| Paratek Pharmaceuticals, INC. | $146.69 | 2021-2024 | Nuzyra |
| Biohaven Pharmaceutical Holding Company LTD. | $128.12 | 2022 | |
| Gilead Sciences, INC. | $126.71 | 2019-2020 | |
| Ironwood Pharmaceuticals, INC | $126.63 | 2019-2020 | |
| E.R. Squibb & Sons, L.L.C. | $105.81 | 2019-2022 | |
| Phathom Pharmaceuticals, INC. | $101.55 | 2024-2025 | Voquezna |
| Arbor Pharmaceuticals, INC. | $88.82 | 2019-2020 | |
| Almatica Pharma LLC | $85.68 | 2022-2024 | Loreev Xr |
| Dexcom, INC. | $83.18 | 2022-2023 | Dexcom G6 Transmitter |
| Astellas Pharma US INC | $83.00 | 2020-2021 | |
| Kowa Pharmaceuticals America, INC. | $72.18 | 2021-2025 | Zoryve |
| Horizon Therapeutics Plc | $60.69 | 2021-2023 | Krystexxa |
| Jazz Pharmaceuticals INC. | $58.82 | 2021 | |
| Corcept Therapeutics | $57.61 | 2025 | Korlym |
| Supernus Pharmaceuticals, INC. | $40.39 | 2019-2020 | |
| Becton, Dickinson and Company | $37.00 | 2024 | |
| Teva Pharmaceuticals USA, INC. | $34.46 | 2020-2021 | |
| Exact Sciences Corporation | $34.19 | 2024-2025 | The Cologuard Plus Collection Kit, Cologuard Collection Kit |
| Medtronic, INC. | $22.39 | 2024 | Intellis Adaptivestim |
| Mylan Specialty L.P. | $21.89 | 2022 | |
| Amneal Pharmaceuticals LLC | $20.33 | 2020 | |
| Antares Pharma, INC. | $19.73 | 2020 | |
| Alk-Abello, INC | $19.38 | 2023 | Grastek, Odactra, Ragwitek |
| Phadia US INC. | $19.20 | 2025 | Immunocap |
| Inari Medical, INC. | $18.41 | 2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Axsome Therapeutics, INC. | $16.65 | 2025 | Auvelity |
| Intra-Sana Laboratories | $16.19 | 2023 | Glycate, Reltone 200 Mg, Reltone 400 Mg |
| Ultragenyx Pharmaceutical INC. | $16.16 | 2022 | |
| Sun Pharmaceutical Industries INC. | $15.89 | 2020 | |
| Biohaven Pharmaceuticals, INC. | $15.64 | 2021 | |
| Vistapharm, INC. | $11.65 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Lanese listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
The CSV has this whole record: totals, yearly figures, every listed company, payment types, and product associations.
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.